Wexton, who represents an area of suburban Northern Virginia
outside Washington, said she would serve out her current
two-year term, which ends in January 2025, but would not seek a
fourth term and would instead spend time with her husband and
two sons.
The 55-year-old congresswoman announced in April that she had
been diagnosed with Parkinson's but would continue to work while
being treated for the disease, which was affecting her speech.
Wexton said on Monday that after additional testing doctors had
modified her diagnosis to a rare brain disorder called
Progressive supranuclear palsy (PSP) that she described in a
written statement as "a kind of Parkinson’s on steroids."
“I’ve always believed that honesty is the most important value
in public service, so I want to be honest with you now, this new
diagnosis is a tough one. There is no ‘getting better’ with PSP.
I'll continue treatment options to manage my symptoms, but they
don't work as well as they do for Parkinson's."
Progressive supranuclear palsy is caused by a deterioration of
brain cells that affect body movements, according to a
description by the Mayo Clinic. It causes problems with
coordination, thinking, walking, eye movement, and swallowing.
"There is currently no treatment that effectively stops or slows
the progression of PSP, and symptoms usually do not respond well
to medications," the National Institute of Neurological
Disorders and Stroke said on its website.
Wexton defeated Republican Barbara Comstock in 2018 to flip a
House seat held by Republicans for decades and was reelected by
a narrow margin during the 2022 midterms.
Her decision not to seek reelection could create an opportunity
for Republicans to re-take the seat, without an incumbent
Democrat in the race.
The seat could prove crucial as Republicans look to hold on to
the narrow balance of power in the House they gained in the
midterm elections and Democrats try to regain the majority.
(Reporting by Katharine Jackson; additional reporting by Dan
Whitcomb; editing by Jonathan Oatis and Bill Berkrot)
[© 2023 Thomson Reuters. All rights
reserved.] Copyright 2022 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content.
|
|